Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
The Australasian Journal of Dermatology|December 17, 2025
Cutaneous Infiltration of Waldenstrom's Macroglobulinaemia-A Two-Case Series of a Diagnostically Challenging PresentationMonica Narula, Patrick D Mahar, Edwin Wee Hian Tan, et al.International Journal of Molecular Sciences|July 29, 2025
Circulating Tumour DNA Is a Biomarker of Response in Angioimmunoblastic T-Cell LymphomaCostas Kleanthes Yannakou, Simon Wu, Karthik Rajah, et al.Expert Review of Hematology|October 13, 2025
Updated guidelines in the treatment of myeloma bone disease in 2025: consensus statement by the Medical and Scientific Advisory Group of Australia (MSAG) to Myeloma AustraliaAngelina Yong, Kate Vandyke, Bradley Augustson, et al.Leukemia & Lymphoma|December 15, 2018
A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphomaGreg Hapgood, Janey M Stone, Diana Zannino, et al.BJU International|April 29, 2017
Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population-based studyVictoria White, David J T Marco, Damien Bolton, et al.Internal Medicine Journal|February 8, 2018
Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myelomaHang Quach, Simon Benson, Helen Haysom, et al.American Journal of Hematology|February 6, 2015
The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefitSimon J Harrison, Hang Quach, Emma Link, et al.Frontiers in Nutrition|January 23, 2023
Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control studyMichael K Odutola, Marina T van Leeuwen, Julie K Bassett, et al.Epigenomics|December 19, 2015
Global measures of peripheral blood-derived DNA methylation as a risk factor in the development of mature B-cell neoplasmsNicole Wong Doo, Enes Makalic, JiHoon E Joo, et al.Internal Medicine Journal|December 26, 2023
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignanciesAshlea Campbell, Benjamin Teh, Stephen Mulligan, et al.Pageof 3